Genetic Heterogeneity of Autosomal Dominant Hypercholesterolemia in Mexico
Abstract
Background Familial hypercholesterolemia (FH) and familial defective apolipoprotein B-100 (FDB) are relatively common lipid disorders caused by mutations of the low-density lipoprotein receptor (LDLR) and apolipoprotein B (apoB) genes, respectively. A third locus on chromosome 1p34.1-p32 was recently linked to FH and the responsible gene has been identified [protein convertase subtilisin/kexin type 9 (PCSK9)]. Methods We assessed the contribution of the LDLR, apoB, and PCSK9 genes as cause of FH in Mexico. Forty six unrelated probands, as well as 68 affected and 60 healthy relatives, were included. Results All index cases were diagnosed as having heterozygous autosomal dominant FH. Seventeen of the 46 index cases had LDLR gene mutations, four of which were novel (Fs92ter108, C268R, Q718X, and Fs736ter743); and only one patient had an apoB mutation (R3500Q). We sequenced the PCSK9 gene in the remainder of the 28 probands with no identified LDLR or APOB gene defects; however, no PCSK9 mutations were found, including one large kindred with positive linkage to the 1p34.1-32 locus (multipoint LOD score of 3.3) and two small pedigrees. Linkage was excluded from these three loci in at least four kindreds suggesting that other yet uncharacterized genes are involved. Conclusions Our results underline substantial genetic heterogeneity for FH in the Mexican population.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rare coding variation in MYLIP did not account for familial hypercholesterolemia in these Mexican subjects with unknown etiology of FH.
“Thus, rare coding variation in MYLIP did not account for FH in these Mexican subjects with unknown etiology of FH (12).”
From The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans (2011) · cites this paper as [12]
Cited by
Sorted by citations
Weissglas-Volkov, D., Calkin, A. C., Tusie-Luna, T., Sinsheimer, J. S., Zelcer, N., Riba, L., Tino, A. M. V., Ordoñez-Sánchez, M. L., Cruz-Bautista, I., Aguilar-Salinas, C. A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45504 · Cited by 66 · see citing works
Self-citation
- Authors
- Robles-Osorio, L., Huerta-Zepeda, A., Ordóñez, M. L., Canizales-Quinteros, S., Díaz-Villaseñor, A., Gutiérrez-Aguilar, R., Riba, L., Huertas-Vázquez, A., Rodríguez-Torres, M., Gómez-Díaz, R. A., Salinas, S., Ongay-Larios, L., Codiz-Huerta, G., Mora-Cabrera, M., Mehta, R., Gómez Pérez, F. J., Rull, J. A., Rabès, J.-P., Tusié-Luna, M. T., Durán-Vargas, S., & Aguilar-Salinas, C. A.
- Affiliations
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Mexican Social Security Institute (MX)
- Universidad Nacional Autónoma de México (MX)
- Hôpital Necker-Enfants Malades (FR)
- Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (MX)
- Venue
- Archives of Medical Research
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 37
- Issue
- 1
- Pages
- 102-108
- ISSN
- 0066-6769 (ISSN-L)
- 0188-4409
- OpenAlex
- W2127199991
- Cited by
- 35
- References
- 0
- Citations by year
- 2025: 2 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 2 · 2016: 4 · 2013: 1 · 2012: 3
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Update notices
- erratum (2006-02-01)
- Open access
- closed
- Locations
- Archives of Medical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Consejo Nacional de Ciencia y Tecnología
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- familial hypercholesterolemia, autosomal dominant hypercholesterolemia, genetic heterogeneity, LDLR mutations, PCSK9, Mexican population
- MeSH terms
- Proprotein Convertase 9, Adult, Apolipoproteins B, Chromosomes, Human, Pair 1, Female, Humans, Hyperlipoproteinemia Type II, Lod Score, Male, Mexico, Middle Aged, Receptors, LDL, Serine Endopeptidases, Genetic Heterogeneity, Quantitative Trait Loci, Proprotein Convertases, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review